DE69819749D1 - Behandlung von stress und vorbehandlng gegen stress - Google Patents

Behandlung von stress und vorbehandlng gegen stress

Info

Publication number
DE69819749D1
DE69819749D1 DE69819749T DE69819749T DE69819749D1 DE 69819749 D1 DE69819749 D1 DE 69819749D1 DE 69819749 T DE69819749 T DE 69819749T DE 69819749 T DE69819749 T DE 69819749T DE 69819749 D1 DE69819749 D1 DE 69819749D1
Authority
DE
Germany
Prior art keywords
radiation
ozone
stress
mild heating
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69819749T
Other languages
English (en)
Other versions
DE69819749T2 (de
Inventor
Pavel Hamet
Johanne Tremblay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre de Recherche du Centre Hospitalier de lUniversite de Montreal
Vasogen Ireland Ltd
Original Assignee
Centre de Recherche du Centre Hospitalier de lUniversite de Montreal
Vasogen Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2218625 external-priority patent/CA2218625A1/en
Priority claimed from CA 2230836 external-priority patent/CA2230836A1/en
Application filed by Centre de Recherche du Centre Hospitalier de lUniversite de Montreal, Vasogen Ireland Ltd filed Critical Centre de Recherche du Centre Hospitalier de lUniversite de Montreal
Publication of DE69819749D1 publication Critical patent/DE69819749D1/de
Application granted granted Critical
Publication of DE69819749T2 publication Critical patent/DE69819749T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Heads (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
DE69819749T 1997-09-12 1998-09-11 Behandlung von stress und vorbehandlung gegen stress Expired - Fee Related DE69819749T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US5878297P 1997-09-12 1997-09-12
US58782P 1997-09-12
US5917297P 1997-09-17 1997-09-17
US59172P 1997-09-17
CA2218625 1997-10-20
CA 2218625 CA2218625A1 (en) 1997-09-12 1997-10-20 Stress treatment and preconditioning against stress
CA2230836 1998-02-27
CA 2230836 CA2230836A1 (en) 1998-02-27 1998-02-27 Inducing resistance to ischemic stresses
PCT/CA1998/000869 WO1999013890A1 (en) 1997-09-12 1998-09-11 Treatment of stress and preconditioning against stress

Publications (2)

Publication Number Publication Date
DE69819749D1 true DE69819749D1 (de) 2003-12-18
DE69819749T2 DE69819749T2 (de) 2004-09-30

Family

ID=27427399

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819749T Expired - Fee Related DE69819749T2 (de) 1997-09-12 1998-09-11 Behandlung von stress und vorbehandlung gegen stress

Country Status (13)

Country Link
EP (1) EP1011696B1 (de)
JP (1) JP4141636B2 (de)
AT (1) ATE253922T1 (de)
AU (1) AU741181B2 (de)
DE (1) DE69819749T2 (de)
DK (1) DK1011696T3 (de)
EA (1) EA003232B1 (de)
ES (1) ES2210814T3 (de)
HK (1) HK1031322A1 (de)
IL (3) IL135018A0 (de)
NZ (1) NZ503770A (de)
PT (1) PT1011696E (de)
WO (1) WO1999013890A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ512849A (en) * 1999-01-12 2003-02-28 Ct De Rech Du Ct Hospitalier D Pre-conditioning against cell death
US7045124B1 (en) 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
PT1214037E (pt) * 1999-09-16 2004-08-31 Vasogen Ireland Ltd Aparelho e processo para o condicionamento de sangue de mamiferos
AU7500200A (en) 1999-09-24 2001-04-30 Vasogen Ireland Limited Combined therapies for atherosclerosis treatment
CA2296997A1 (en) 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
DK1427394T3 (da) * 2001-09-18 2007-06-11 Vasogen Ireland Ltd Fremgangsmåde til acceleration af restituering fra traume ved anvendelse af apoptose-imiterende syntetiske eller naturlige enheder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332087T2 (de) * 1992-02-07 2002-10-24 Etobicocke Vasogen Inc. Verfahren zur erhöhung den stickoxidkonzentration im blut
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
JPH08652A (ja) * 1994-06-24 1996-01-09 Oskar:Kk 男性機能回復補助器具
CA2194485C (en) * 1995-05-05 2001-09-18 Anthony Ernest Bolton Endothelial lining effects and treatment of vasospastic disorders
JPH09227394A (ja) * 1995-12-22 1997-09-02 Taisho Pharmaceut Co Ltd 経口投与用組成物

Also Published As

Publication number Publication date
JP4141636B2 (ja) 2008-08-27
PT1011696E (pt) 2004-03-31
IL135018A0 (en) 2001-05-20
AU9148098A (en) 1999-04-05
IL135018A (en) 2006-06-11
ES2210814T3 (es) 2004-07-01
NZ503770A (en) 2002-10-25
HK1031322A1 (en) 2001-06-15
IL135014A0 (en) 2001-05-20
WO1999013890A1 (en) 1999-03-25
AU741181B2 (en) 2001-11-22
DE69819749T2 (de) 2004-09-30
EA003232B1 (ru) 2003-02-27
JP2001516723A (ja) 2001-10-02
ATE253922T1 (de) 2003-11-15
EP1011696A1 (de) 2000-06-28
DK1011696T3 (da) 2004-03-15
EA200000312A1 (ru) 2001-04-23
EP1011696B1 (de) 2003-11-12

Similar Documents

Publication Publication Date Title
UY24805A1 (es) Peptidos y compuestos que se enlazan al receptor de la trombopoyetina
BRPI0213786B8 (pt) peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
ATE477816T1 (de) Botulinum toxin zur behandlung von akuten verletzungen der skelettmuskeln
BG101284A (en) Compounds and methods for cancer treatment
UA32429C2 (uk) Засіб для лікування нетримання сечі
DE69829112D1 (de) Butyrate derivaten zur behandlung von fibromyalgia und chronische müdigkeit-syndrom
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ES2196530T3 (es) Compuestos de ruptura para inactivar patogenos.
BR9911161A (pt) Processos para o tratamento de um volume particular de tecido de planta ou animal, para produção de pelo menos um agente fotoativado em um volume particular de material, para o tratamento médico de um volume particular de tecido, e, aparelhos para o tratamento de um volume particular de tecido de planta ou animal e, para administração de um tratamento médico fotodinâmico.
BR9916879A (pt) Composição e método para tratamento do câncer utilizando óleos essenciais vegetais naturais
ATE286392T1 (de) Photodynamische behandlung von synovium
BR9405763A (pt) Processo para tratar fluido corpóreo processo para tratar produto de sangue e processo para fornecer produtos de sangue a paciente
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
AR031250A1 (es) Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon
DE3788231D1 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
PT1368054E (pt) Utilização de proteínas da cadeia neural para o tratamento de tumores
ATE253922T1 (de) Behandlung von stress und vorbehandlng gegen stress
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
ES2164914T3 (es) Medicamentos de inmunoterapia que contienen anticuerpos que detectan especificamente el antigeno mhcii del paciente a tratar.
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
ES2170798T3 (es) Benzopiranos y su uso como agentes terapeuticos.
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
ES2176309T3 (es) Tratamiento humedo de pieles de cuero.
DE69629436D1 (de) Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungen
MY120530A (en) Combination preparation for use in dementia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee